These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9854426)

  • 1. Immunoexpression of mutant p53 and human papillomavirus related E6 oncoprotein in anal malignancies.
    Gupta S; Sharma BK
    Indian J Exp Biol; 1998 Sep; 36(9):875-8. PubMed ID: 9854426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour suppressor gene proteins in oesophageal cancer.
    Agarwal SK; Chatterji A; Bhambhani S; Sharma BK
    Indian J Exp Biol; 1998 Jun; 36(6):559-63. PubMed ID: 9731468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of mutant P53 protein and human papillomavirus-related E6 protein in anal cancers.
    Jakate SM; Saclarides TJ
    Dis Colon Rectum; 1993 Nov; 36(11):1026-9. PubMed ID: 8223054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of TP53 in Cervical carcinogenesis.
    Tommasino M; Accardi R; Caldeira S; Dong W; Malanchi I; Smet A; Zehbe I
    Hum Mutat; 2003 Mar; 21(3):307-12. PubMed ID: 12619117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
    Lu DW; El-Mofty SK; Wang HL
    Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human telomerase reverse transcriptase activated by E6 oncoprotein is required for human papillomavirus-16/18-infected lung tumorigenesis.
    Cheng YW; Wu TC; Chen CY; Chou MC; Ko JL; Lee H
    Clin Cancer Res; 2008 Nov; 14(22):7173-9. PubMed ID: 19010833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infection and p53 nuclear overexpression in anal canal carcinoma.
    Indinnimeo M; Cicchini C; Stazi A; Giarnieri E; French D; Limiti MR; Ghini C; Vecchione A
    J Exp Clin Cancer Res; 1999 Mar; 18(1):47-52. PubMed ID: 10374676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of E6 induced degradation of p53 is not sufficient for stabilization of p53 protein in cervical tumour derived cell lines.
    Mantovani F; Banks L
    Oncogene; 1999 Jun; 18(22):3309-15. PubMed ID: 10362351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes.
    Kawamata Y; Mitsuhashi A; Unno Y; Kado S; Shino Y; Uesugi K; Eguchi O; Ishii J; Seki K; Sekiya S; Shirasawa H
    Int J Oncol; 2002 Sep; 21(3):561-7. PubMed ID: 12168100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV-16 E6 oncoprotein induces mutations via p53-dependent and -independent pathways.
    Kim HJ; Guo W; Park NH
    Oncol Rep; 2000; 7(4):707-12. PubMed ID: 10854530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6.
    Pim D; Banks L
    Oncogene; 1999 Dec; 18(52):7403-8. PubMed ID: 10602499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Human papillomavirus type 16 E6 oncogene and expression of P53, RB and PCNA in human cervical carcinoma].
    Bian J; Yu X; Dong J; Zhao W; Zhou Y; Luan Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):271-3. PubMed ID: 15617346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between expression of human papillomavirus 16/18 E6 oncoprotein and survival in patients with stage I non-small cell lung cancer.
    Hsu NY; Cheng YW; Chan IP; Ho HC; Chen CY; Hsu CP; Lin MH; Chou MC
    Oncol Rep; 2009 Jan; 21(1):81-7. PubMed ID: 19082446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the E6-p53 interaction in the molecular pathogenesis of HPV.
    Thomas M; Pim D; Banks L
    Oncogene; 1999 Dec; 18(53):7690-700. PubMed ID: 10618709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of p53 lysine mutants to ubiquitin-directed degradation targeted by human papillomavirus E6.
    Crook T; Ludwig RL; Marston NJ; Willkomm D; Vousden KH
    Virology; 1996 Mar; 217(1):285-92. PubMed ID: 8599213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner.
    López-Ocejo O; Viloria-Petit A; Bequet-Romero M; Mukhopadhyay D; Rak J; Kerbel RS
    Oncogene; 2000 Sep; 19(40):4611-20. PubMed ID: 11030150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro.
    Slebos RJ; Kessis TD; Chen AW; Han SM; Hedrick L; Cho KR
    Virology; 1995 Apr; 208(1):111-20. PubMed ID: 11831691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-independent abrogation of a postmitotic checkpoint contributes to human papillomavirus E6-induced polyploidy.
    Liu Y; Heilman SA; Illanes D; Sluder G; Chen JJ
    Cancer Res; 2007 Mar; 67(6):2603-10. PubMed ID: 17363579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.